10x Genomics, Inc. (TXG): Operating Income
-$60.98M
Year ended 2025-12-31
-$88.38M
Trailing 12 months to 2026-06-30
| Period ended | Operating Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$60.98M | n/m | 2026-02-13, From 2025-01-01 |
| 2024-12-31 | -$194.56M | n/m | 2026-02-13, From 2024-01-01 |
| 2023-12-31 | -$265.33M | n/m | 2026-02-13, From 2023-01-01 |
| 2022-12-31 | -$167.94M | n/m | 2025-02-13, From 2022-01-01 |
| 2021-12-31 | -$52.25M | n/m | 2024-02-15, From 2021-01-01 |
| 2020-12-31 | -$534.14M | n/m | 2023-02-16, From 2020-01-01 |
| 2019-12-31 | -$30.57M | n/m | 2022-02-18, From 2019-01-01 |
| 2018-12-31 | -$110.76M | n/m | 2021-02-26, From 2018-01-01 |
| 2017-12-31 | -$18.38M | n/a | 2020-02-27, From 2017-01-01 |
Operating Income at similar companies
| Company | Year ended | Operating Income | Change YoY |
|---|---|---|---|
| 10x Genomics, Inc. (TXG) | 2025-12-31 | -$60.98M | n/m |
| Cytek Biosciences, Inc. (CTKB) | 2025-12-31 | -$40.38M | n/m |
| Pacific Biosciences of California, Inc. (PACB) | 2025-12-31 | -$553.86M | n/m |
| Bio-Rad Laboratories, Inc. (BIO) | 2025-12-31 | $47.20M | -82.5% |
| Revvity, Inc. (RVTY) | 2025-12-28 | $356.63M | +2.9% |
| Quanterix Corp (QTRX) | 2025-12-31 | -$125.54M | n/m |
| Waters Corp (WAT) | 2025-12-31 | $802.59M | -2.9% |
| Bruker Corp (BRKR) | 2025-12-31 | $68.20M | -73.1% |
| Illumina, Inc. (ILMN) | 2025-12-28 | $807.00M | n/m |
Compare TXG, CTKB, PACB, BIO side by side · Screen every company in Laboratory Analytical Instruments ↗